News
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...
This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.
Ovarian cancer often goes undetected until advanced stages. Emerging tools like liquid biopsies and AI offer hope, but ...
New research reveals PD-L1 expression enhances survival in advanced ovarian cancer, linking it to homologous recombination ...
US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.
A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating ...
A recent study published in Genes & Diseases has unveiled a novel mechanism by which the restriction of YWHAB-mediated YAP cytoplasmic retention ...
Ovarian cancer is a type of cancer that forms in ovaries. Cancer develops when genes that control cell growth mutate and start growing abnormally. Eventually, those cells begin to multiply at a ...
In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...
Is PCOS a True Autoimmune Disease? Researchers have also attempted to prove the presence of antiovarian autoantibodies among women with PCOS. 12,15 Petrikova et al identified a subgroup of women with ...
Tanner Martin shared his cancer journey on social media. A 30-year-old influencer who documented his cancer journey online has announced his own death in a social media video. Tanner Martin made ...
New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with platinum-resistant ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results